(ATGE) Adtalem Global Education - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00737L1035
ATGE: Education, Degrees, Certificates, Medicine, Nursing, Veterinary
Adtalem Global Education Inc. (NYSE: ATGE) is a leading provider of workforce solutions and higher education, operating through three core segments: Chamberlain, Walden, and Medical and Veterinary. The company specializes in offering degree and non-degree programs across a wide range of fields, including healthcare, nursing, business, and public policy. Its institutions, such as Chamberlain University and Walden University, are well-known for their focus on online and hybrid education models, catering to working professionals and underserved populations.
The companys Medical and Veterinary segment includes prestigious institutions like the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. These institutions are particularly notable for their global reach, attracting students from around the world, especially in the Caribbean region. Adtalems focus on healthcare and veterinary education positions it strategically in high-demand fields with strong growth prospects.
Formerly known as DeVry Education Group Inc., Adtalem rebranded in 2017 to reflect its expanded global focus and diversified education offerings. The company has a long history, dating back to its incorporation in 1987, and is headquartered in Chicago, Illinois. Its transition to Adtalem marked a shift toward more specialized and globally oriented education programs, aligning with emerging trends in workforce development and online learning.
From a financial perspective, Adtalem operates with a market capitalization of approximately $4 billion, making it a mid-sized player in the education sector. The companys price-to-earnings (P/E) ratio stands at 20.40, with a forward P/E of 19.46, indicating moderate valuation levels. Its price-to-book (P/B) ratio of 2.83 suggests that investors value its assets and future growth potential. The price-to-sales (P/S) ratio of 2.44 reflects a reasonable valuation relative to its revenue generation.
For investors and fund managers, Adtalems focus on healthcare and veterinary education is particularly noteworthy, given the growing demand for skilled professionals in these fields. The companys global footprint and emphasis on online education also position it well to capitalize on the increasing demand for flexible and accessible learning options. However, like many education companies, Adtalem must navigate regulatory challenges and evolving market dynamics, particularly in the for-profit education sector.
Additional Sources for ATGE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ATGE Stock Overview
Market Cap in USD | 3,502m |
Sector | Consumer Defensive |
Industry | Education & Training Services |
GiC Sub-Industry | Education Services |
IPO / Inception | 1991-06-21 |
ATGE Stock Ratings
Growth 5y | 88.5% |
Fundamental | 65.1% |
Dividend | 15.7% |
Rel. Strength Industry | 81.7 |
Analysts | 4.5/5 |
Fair Price Momentum | 120.27 USD |
Fair Price DCF | 90.06 USD |
ATGE Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 52.4% |
ATGE Growth Ratios
Growth Correlation 3m | 53.6% |
Growth Correlation 12m | 94.3% |
Growth Correlation 5y | 83.8% |
CAGR 5y | 32.26% |
CAGR/Max DD 5y | 0.61 |
Sharpe Ratio 12m | 2.09 |
Alpha | 88.01 |
Beta | 1.26 |
Volatility | 38.73% |
Current Volume | 713.7k |
Average Volume 20d | 451.8k |
As of March 16, 2025, the stock is trading at USD 97.32 with a total of 713,691 shares traded.
Over the past week, the price has changed by +7.16%, over one month by -5.94%, over three months by +6.40% and over the past year by +100.37%.
Yes, based on ValueRay Fundamental Analyses, Adtalem Global Education (NYSE:ATGE) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 65.08 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATGE as of March 2025 is 120.27. This means that ATGE is currently undervalued and has a potential upside of +23.58% (Margin of Safety).
Adtalem Global Education has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ATGE.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ATGE Adtalem Global Education will be worth about 134.3 in March 2026. The stock is currently trading at 97.32. This means that the stock has a potential upside of +38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 119.7 | 23% |
Analysts Target Price | 104 | 6.9% |
ValueRay Target Price | 134.3 | 38% |